NEXTAGE THERAPEUTI

The current price of NXTG is 77.5 ILA — it has increased by 5.87% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange NEXTAGE THERAPEUTI stocks are traded under the ticker NXTG.

NXTG stock is 7.88% volatile and has beta coefficient of 0.15. Check out the list of the most volatile stocks — is NEXTAGE THERAPEUTI there?

Yes, you can track NEXTAGE THERAPEUTI financials in yearly and quarterly reports right on TradingView.

NXTG stock has risen by 14.64% compared to the previous week, the month change is a 101.30% rise, over the last year NEXTAGE THERAPEUTI has showed a 60.79% increase.

NXTG net income for the last quarter is ‪−1.64 M‬ ILS, while the quarter before that showed ‪−2.24 M‬ ILS of net income which accounts for 26.75% change. Track more NEXTAGE THERAPEUTI financial stats to get the full picture.

No, NXTG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, NXTG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEXTAGE THERAPEUTI stock right from TradingView charts — choose your broker and connect to your account.

NXTG reached its all-time high on Feb 2, 2021 with the price of 600.0 ILA, and its all-time low was 25.6 ILA and was reached on Jun 6, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 26, 2024, the company has 31.00 employees. See our rating of the largest employees — is NEXTAGE THERAPEUTI on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEXTAGE THERAPEUTI technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEXTAGE THERAPEUTI stock shows the buy signal. See more of NEXTAGE THERAPEUTI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEXTAGE THERAPEUTI EBITDA is ‪−3.86 M‬ ILS, and current EBITDA margin is −440.53%. See more stats in NEXTAGE THERAPEUTI financial statements.